Tapewire

Nasdaq · USD

SDGR

Schrodinger, Inc.

Export transactions ↓
Tapewire entity
4667
SEC CIK
0001490978
Parsed reports
322

Last 12 months

Inside the activity.

0 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202604
Mar 2026010
Apr 202603
May 202600
Jun 202600
Jul 202601
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 21, 2024 Filed Mar 22, 2024 20:25 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $27.51 $0.00
Disclosure

SEC source: 0001490978-24-000024 · wk-form4_1711139131.xml · derivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-21

F1 · derivative.exercise_date: The option was granted on March 21, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 17:05 UTC
Lorton Kenneth PatrickEVP, CTO & COO, Software
Exercise / conversionStock Option (right to buy) · Derivative 5,574 $0.00 Strike: $4.34 $0.00
Disclosure

SEC source: 0001628280-24-009688 · wk-form4_1709849123.xml · derivative · entry 2

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,574 shares

Expires 2028-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option was granted on November 29, 2018 and is fully vested.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 17:05 UTC
Lorton Kenneth PatrickEVP, CTO & COO, Software
Exercise / conversionCommon Stock 5,574 $4.34 $24,191.16
Disclosure

SEC source: 0001628280-24-009688 · wk-form4_1709849123.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 6,128 unvested RSUs.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 16:45 UTC
Lorton Kenneth PatrickEVP, CTO & COO, Software
GrantStock Option (right to buy) · Derivative 60,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008961 · wk-form4_1709675098.xml · derivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:13 UTC GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · derivative · entry 3

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-03-04

F3 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:13 UTC SaleCommon Stock 3,315 $26.35 $87,360.20
Disclosure

SEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · nonDerivative · entry 2

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,685

F2 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on August 16, 2022 and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of the PRSUs on March 4, 2024. The sale does not represent a discretionary trade by the reporting person.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:13 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · nonDerivative · entry 1

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

F1 · kind: Represents the portion of the performance-based restricted stock units ("PRSUs") that were awarded to the reporting person on August 18, 2022 in connection with the commencement of his employment that vested on March 4, 2024 following certification by the compensation committee of the issuer's board of directors of the level of achievement of certain performance metrics for the PRSUs.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:49 UTC
Farid RamyDirector · President & CEO
GrantStock Option (right to buy) · Derivative 87,271 $0.00 Strike: $27.76 $0.00
Disclosure

SEC source: 0001628280-24-008968 · wk-form4_1709675347.xml · derivative · entry 2

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,271

Underlying: Common Stock · 87,271 shares

Expires 2034-03-04

F2 · derivative.exercise_date: The option was granted on March 4, 2024. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:49 UTC
Farid RamyDirector · President & CEO
GrantStock Option (right to buy) · Derivative 126,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008968 · wk-form4_1709675347.xml · derivative · entry 1

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,000

Underlying: Common Stock · 126,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:48 UTC
Herman JennySVP & Controller
GrantStock Option (right to buy) · Derivative 14,625 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008966 · wk-form4_1709675289.xml · derivative · entry 2

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,625

Underlying: Common Stock · 14,625 shares

Expires 2034-03-04

F3 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:48 UTC
Herman JennySVP & Controller
GrantCommon Stock 7,313 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-008966 · wk-form4_1709675289.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,074

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 4, 2024 and will vest in equal installments on each of March 5 of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 13,313 unvested RSUs.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:44 UTC
Akinsanya KarenPresident of R&D, Therapeutics
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008959 · wk-form4_1709675058.xml · derivative · entry 1

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:43 UTC
Tran YvonneEVP, CLO & CPO
GrantStock Option (right to buy) · Derivative 60,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008957 · wk-form4_1709675023.xml · derivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:43 UTC
Dugan MargaretChief Medical Officer
GrantStock Option (right to buy) · Derivative 60,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008955 · wk-form4_1709674967.xml · derivative · entry 1

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:39 UTC GrantStock Option (right to buy) · Derivative 60,000 $0.00 Strike: $25.24 $0.00
Disclosure

SEC source: 0001628280-24-008948 · wk-form4_1709674728.xml · derivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

Read SEC document
February 12, 2024 Filed Feb 13, 2024 19:35 UTC
Lorton Kenneth PatrickEVP, CTO & COO, Software
SaleCommon Stock 901 $28.29 $25,489.29
Disclosure

SEC source: 0001490978-24-000002 · wk-form4_1707870905.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,487

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 9, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 6,128 unvested RSUs.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 00:39 UTC
Tran YvonneEVP, CLO & CPO
SaleCommon Stock 758 $28.29 $21,443.82
Disclosure

SEC source: 0001490978-24-000008 · wk-form4_1707871134.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,963

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 8, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 5,693 unvested RSUs.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 00:37 UTC SaleCommon Stock 1,205 $27.55 $33,197.75
Disclosure

SEC source: 0001490978-24-000006 · wk-form4_1707871058.xml · nonDerivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,340

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on June 13, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 7,909 unvested RSUs.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 00:36 UTC
Herman JennySVP & Controller
SaleCommon Stock 787 $28.29 $22,264.23
Disclosure

SEC source: 0001490978-24-000004 · wk-form4_1707870979.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,761

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 11, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 6,000 unvested RSUs.

Read SEC document
September 15, 2023 Filed Sep 18, 2023 20:36 UTC
Herman JennySVP & Controller
Exercise / conversionStock Option (right to buy) · Derivative 4,545 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001490978-23-000101 · wk-form4_1695069363.xml · derivative · entry 2

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,545 shares

Expires 2023-10-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted on October 4, 2013 and is fully vested.

Read SEC document
September 15, 2023 Filed Sep 18, 2023 20:36 UTC
Herman JennySVP & Controller
Exercise / conversionCommon Stock 4,545 $1.20 $5,454.00
Disclosure

SEC source: 0001490978-23-000101 · wk-form4_1695069363.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 8,000 unvested RSUs.

Read SEC document
August 09, 2023 Filed Aug 10, 2023 16:37 UTC
Lorton Kenneth PatrickEVP & Chief Technology Officer
SaleCommon Stock 10,000 $40.06 $400,642.00
Disclosure

SEC source: 0001490978-23-000097 · wk-form4_1691699806.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,388

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes of this Form 4.

F3 · balance_after: Includes 8,170 unvested RSUs.

Read SEC document
August 09, 2023 Filed Aug 10, 2023 20:38 UTC
Dugan MargaretChief Medical Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $39.89 $0.00
Disclosure

SEC source: 0001490978-23-000099 · wk-form4_1691699891.xml · derivative · entry 2

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2033-08-09

F3 · derivative.exercise_date: The option was granted on August 9, 2023 under the Issuer's 2021 Inducement Equity Incentive Plan. The shares underlying the option are scheduled to vest with respect to 25% of the shares on July 31, 2024 and the remainder are scheduled to vest in equal monthly installments through July 31, 2027.

Read SEC document
August 09, 2023 Filed Aug 10, 2023 20:38 UTC
Dugan MargaretChief Medical Officer
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000099 · wk-form4_1691699891.xml · nonDerivative · entry 1

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Inducement Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on August 9, 2023 and will vest in equal installments on each of October 15, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 15,000 unvested RSUs.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 20:16 UTC
Tran YvonneEVP, CLO & CPO
Exercise / conversionStock Option (right to buy) · Derivative 12,040 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · derivative · entry 3

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,619

Underlying: Common Stock · 12,040 shares

Expires 2030-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F3 · derivative.exercise_date: The option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder vest in equal monthly installments through February 5, 2024.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 20:16 UTC
Tran YvonneEVP, CLO & CPO
SaleCommon Stock 12,040 $50.00 $602,000.00
Disclosure

SEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · nonDerivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,721

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · balance_after: Includes 7,590 unvested RSUs.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 20:16 UTC
Tran YvonneEVP, CLO & CPO
Exercise / conversionCommon Stock 12,040 $17.00 $204,680.00
Disclosure

SEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · balance_after: Includes 7,590 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:00 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000080 · wk-form4_1686949225.xml · derivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:00 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000080 · wk-form4_1686949225.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · ownership.direct: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:01 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000081 · wk-form4_1686949266.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:01 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000081 · wk-form4_1686949266.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:00 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000079 · wk-form4_1686949194.xml · derivative · entry 2

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:00 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000079 · wk-form4_1686949194.xml · nonDerivative · entry 1

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:57 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000078 · wk-form4_1686949060.xml · derivative · entry 2

GINSBERG GARY L · CIK 0001236136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:57 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000078 · wk-form4_1686949060.xml · nonDerivative · entry 1

GINSBERG GARY L · CIK 0001236136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:56 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000077 · wk-form4_1686949008.xml · derivative · entry 4

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F4 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:56 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000077 · wk-form4_1686949008.xml · nonDerivative · entry 1

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 510,700

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:56 UTC
Sender GaryDirector
GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000076 · wk-form4_1686948952.xml · derivative · entry 2

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:56 UTC
Sender GaryDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000076 · wk-form4_1686948952.xml · nonDerivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:55 UTC
OBEROI ARUNDirector
GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000075 · wk-form4_1686948913.xml · derivative · entry 2

OBEROI ARUN · CIK 0001275887 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:55 UTC
OBEROI ARUNDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000075 · wk-form4_1686948913.xml · nonDerivative · entry 1

OBEROI ARUN · CIK 0001275887 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:54 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $45.26 $0.00
Disclosure

SEC source: 0001490978-23-000074 · wk-form4_1686948867.xml · derivative · entry 2

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 20:54 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001490978-23-000074 · wk-form4_1686948867.xml · nonDerivative · entry 1

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 6,250 unvested RSUs.

Read SEC document
May 23, 2023 Filed May 24, 2023 17:16 UTC
Lorton Kenneth PatrickEVP & Chief Technology Officer
SaleCommon Stock 10,000 $40.06 $400,587.00
Disclosure

SEC source: 0001490978-23-000057 · wk-form4_1684962973.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,388

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes of this Form 4.

F3 · balance_after: Includes 8,170 unvested RSUs.

Read SEC document
May 23, 2023 Filed May 24, 2023 21:19 UTC
Tran YvonneEVP, CLO & CPO
Exercise / conversionStock Option (right to buy) · Derivative 7,960 $4.34 Strike: $4.34 $34,546.40
Disclosure

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · derivative · entry 8

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,902

Underlying: Common Stock · 7,960 shares

Expires 2028-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F6 · derivative.exercise_date: The option was granted on November 29, 2018 and is fully vested.

Read SEC document
May 23, 2023 Filed May 24, 2023 21:19 UTC
Tran YvonneEVP, CLO & CPO
SaleCommon Stock 7,960 $40.01 $318,461.29
Disclosure

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 5

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,721

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(4) of this Form 4.

F2 · balance_after: Includes 7,590 unvested RSUs

Read SEC document
May 23, 2023 Filed May 24, 2023 21:19 UTC
Tran YvonneEVP, CLO & CPO
Exercise / conversionCommon Stock 7,960 $4.34 $34,546.40
Disclosure

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 4

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · balance_after: Includes 7,590 unvested RSUs

Read SEC document
May 22, 2023 Filed May 23, 2023 21:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 14,850 $0.00 Strike: $11.52 $0.00
Disclosure

SEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · derivative · entry 3

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,020

Underlying: Common Stock · 14,850 shares

Expires 2029-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

F2 · derivative.exercise_date: The option was granted on December 2, 2019. The shares underlying the option vested with respect to 25% of the shares on December 2, 2020 and the remainder vest in equal monthly installments through December 2, 2023.

Read SEC document
May 22, 2023 Filed May 23, 2023 21:05 UTC SaleCommon Stock 14,850 $35.00 $519,750.00
Disclosure

SEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · nonDerivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

Read SEC document
May 22, 2023 Filed May 23, 2023 21:05 UTC Exercise / conversionCommon Stock 14,850 $11.52 $171,072.00
Disclosure

SEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.